OSOPF yields 2682.25% · MRK yields 2.81%● Live data
📍 OSOPF pulled ahead of the other in Year 1
Combined, OSOPF + MRK cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of OSOPF + MRK for your $10,000?
Osotspa Public Company Limited, together with its subsidiaries manufactures and distributes energy drinks and personal care products worldwide. The company operates in three segments: Beverage, Personal Care, and Others. It offers energy drinks under the M-150, Lipovitan-D, Chalarm, Som in-Sum, White Shark, Shark Energy Drink, and M-Storm brand names; ready-to drink coffee under the M-Presso name; sport drinks under the M-Electrolyte brand; and functional drinks under the Peptein, Peptein Gold, C-Vitt, Calpis Lacto, and Slimma brands. The company also provides baby care products under the Babi Mild brand name; male grooming products under the Exit brand; women beauty care products under the Twelve Plus, Plantstory, Ole Strwaberry, PROhada, and OTG brands; healthcare products under the KRISNAKLAN, Utaitip, Tamjai, YATHAD 4, Yixin, and BANNER brands; and confectionery products under the Botan and Ole brand names. In addition, it provides marketing and property rental services; manufactures and distributes glass, and beverage concentrates and premixes; and distributes food, beverages, and cullet products. Further, the company engages in the import, retail, and wholesale of beverages; investing in other companies; provision of research and development services; electronic commerce business; and education and sale of herbal products. Additionally, it obtains licensing fee for use of trademark, as well as offers manufacturing and distribution services. Osotspa Public Company Limited was founded in 1891 and is based in Bangkok, Thailand.
Full OSOPF Calculator →Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.
Full MRK Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.